Revcovi
Active Ingredient(s): Elapegademase-lvlrFDA Approved: * October 5, 2018
Pharm Company: * LEADIANT BIOSCI INC
Category: Genetic Disorders
Adenosine deaminase deficiency (ADA deficiency) is a metabolic disorder that causes immunodeficiency. It is caused by mutations in the ADA gene. It accounts for about 10–15% of all cases of autosomal recessive forms of severe combined immunodeficiency (SCID) among non-inbred populations.[1] ADA deficiency can present in infancy, childhood, adolescence, or adulthood. Age of onset and severity is related to some 29 known genotypes associated with the disorder.[2... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.